Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial

Authors

Institutions

Publication Details

Journal
Journal for ImmunoTherapy of Cancer
Published
2025-05-01
DOI
https://doi.org/10.1136/jitc-2025-012045
Citations
3
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
6.02
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial

Thierry Roumeguère, Ahmad Awada, L. Staudacher, Véronique Debien et al.
3 citations
Journal for ImmunoTherapy of Cancer
Bladder and Urothelial Cancer Treatments
6.02
article

Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial

Thierry Roumeguère, Ahmad Awada, L. Staudacher, Véronique Debien, Sandrine Rorive, Nuria Kotecki, Emmanuel Seront, Françoise Rothé, Aurélien Carnot, Vincent Vanhaudenarde, Thibault Tricard, Nieves Martínez Chanzá, Jérémy Blanc, Lieveke Ameye, Brieuc Sautois, Vinciane Casert, Philippe Barthélémy, Jean‐Christophe Fantoni, Jan Van den Brande
article en
3 citations

Abstract

No abstract available for this paper.
Journal for ImmunoTherapy of CancerVol. 13(5)
Cliniques Universitaires Saint-Luc (BE), Institut Jules Bordet (BE), Erasmus Hospital (BE), Centre Hospitalier Universitaire de Lille (FR), CHU Ambroise Paré (BE), Institut de Cancérologie Strasbourg (FR), CHU Dinant Godinne UCL Namur (BE), Antwerp University Hospital (BE), Hôpital Saint Joseph (FR), Centre Oscar Lambret (FR), Centre Hospitalier Universitaire de Liège (BE), Hôpital Paris Saint-Joseph (FR), Hôpitaux Universitaires de Strasbourg (FR)
Good health and well-being
Openalex Percentile: Top 4%
Bladder and Urothelial Cancer Treatments
6.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial — Thierry Roumeguère, Ahmad Awada, et al. · Journal for ImmunoTherapy of Cancer (2025) | TGRS Research Map | TGRS